mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.2 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |